# Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

> **NCT00778674** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Benazepril HCl/ Hydrochlorothiazide 20 mg/ 25 mg Tablets

## Key facts

- **NCT ID:** NCT00778674
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2004-10
- **Final completion:** 2004-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778674, "Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00778674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*